Page last updated: 2024-08-21

cepharanthine and Autoimmune Disease

cepharanthine has been researched along with Autoimmune Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, S; Hirano, T; Onda, K; Sugiyama, K; Tanaka, S; Wang, X; Xu, W; Yamada, H1
Byun, S; Lee, E; Lee, KW1
Fukuhara, S; Kagawa, H; Matsuzaki, T; Nagahama, M; Nakayama, S; Nomura, S; Ozaki, Y; Yamaoka, M; Yoshimura, C1

Reviews

2 review(s) available for cepharanthine and Autoimmune Disease

ArticleYear
Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases.
    Pharmacology & therapeutics, 2021, Volume: 217

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autoimmune Diseases; Benzylisoquinolines; Cell Cycle; Down-Regulation; Drug Therapy, Combination; Glucocorticoids; Humans; Mitogen-Activated Protein Kinases; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; T-Lymphocytes; TOR Serine-Threonine Kinases

2021
Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.
    International journal of molecular sciences, 2017, Sep-12, Volume: 18, Issue:9

    Topics: Adaptive Immunity; Animals; Autoimmune Diseases; Autophagy; Benzylisoquinolines; Cholecalciferol; Humans; Immune System Diseases; Immunity, Innate; Indoles; Infections; Isoquinolines; Lysosomes; Maprotiline; Metformin; Neoplasms; Phenols; Pyrroles; Resveratrol; Sirolimus; Spermidine; Stilbenes; Tetrahydroisoquinolines; Trehalose

2017

Other Studies

1 other study(ies) available for cepharanthine and Autoimmune Disease

ArticleYear
Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin.
    Autoimmunity, 1999, Volume: 30, Issue:2

    Topics: Adult; Aged; Alkaloids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Human Platelet; Autoantigens; Autoimmune Diseases; Benzylisoquinolines; Blood Platelets; Combined Modality Therapy; Drug Resistance; Endocytosis; Female; Genetic Predisposition to Disease; Genotype; HLA Antigens; HLA-DQ Antigens; HLA-DQ beta-Chains; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Treatment Outcome

1999